Published in Kidney Int on July 16, 2014
APOL1 Kidney Disease Risk Variants: An Evolving Landscape. Semin Nephrol (2015) 0.97
Characterization of circulating APOL1 protein complexes in African Americans. J Lipid Res (2015) 0.92
Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu. Exp Mol Pathol (2015) 0.89
Race, APOL1 Risk, and eGFR Decline in the General Population. J Am Soc Nephrol (2016) 0.87
Apolipoprotein L1: from obscurity to consistency to controversy. Kidney Int (2015) 0.85
APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study. J Am Soc Nephrol (2015) 0.85
APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans. Nephrol Dial Transplant (2015) 0.84
Apolipoprotein L1 and Kidney Disease in African Americans. Trends Endocrinol Metab (2016) 0.82
APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease. Kidney Int (2016) 0.82
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume. Kidney Int (2016) 0.81
Protein domains of APOL1 and its risk variants. Exp Mol Pathol (2015) 0.80
APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans. BMC Genomics (2015) 0.79
APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV. Am J Kidney Dis (2015) 0.79
Strict blood pressure control associates with decreased mortality risk by APOL1 genotype. Kidney Int (2016) 0.78
Clinical applications of molecular genetic discoveries. Transl Res (2015) 0.75
Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease. PeerJ (2016) 0.75
Risk of ESRD in the United States. Am J Kidney Dis (2016) 0.75
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. Pharmacogenomics J (2016) 0.75
APOL1 Variants: From Parasites to Kidney Function to Cardiovascular Disease. Arterioscler Thromb Vasc Biol (2016) 0.75
How complicated can it be? The link between APOL1 risk variants and lipoprotein heterogeneity in kidney and cardiovascular diseases. Nephrol Dial Transplant (2015) 0.75
SPRINT and Implications for Target Organ Protection in African Americans. Ethn Dis (2016) 0.75
The Apolipoprotein L1 Gene and Cardiovascular Disease. Methodist Debakey Cardiovasc J (2017) 0.75
Renal and Cardiovascular Morbidities Associated with APOL1 Status among African-American and Non-African-American Children with Focal Segmental Glomerulosclerosis. Front Pediatr (2016) 0.75
APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter. Am J Kidney Dis (2017) 0.75
APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults. Kidney Int (2017) 0.75
APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial. KI Rep (2017) 0.75
Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients. PLoS One (2017) 0.75
The limitations of opportunistic epidemiology, pseudopod epidemiology. Eur J Epidemiol (2016) 0.75
APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension). Arterioscler Thromb Vasc Biol (2017) 0.75
Apolipoprotein L1 Genetic Variants Are Associated with Chronic Kidney Disease but Not with Cardiovascular Disease in a Population Referred for Cardiac Catheterization. Cardiorenal Med (2016) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol (2005) 11.00
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet (2010) 5.68
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol (2011) 4.80
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials (2014) 3.50
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int (2012) 3.46
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int (2013) 3.09
Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA (2014) 3.06
Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol (2011) 2.81
APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol (2011) 2.61
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol (2013) 1.98
Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol (2010) 1.92
Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circ Res (2013) 1.82
Genetics of kidney failure and the evolving story of APOL1. J Clin Invest (2011) 1.69
MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol (2011) 1.67
Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol (2013) 1.66
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol (2014) 1.62
Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int (2012) 1.59
APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol (2011) 1.43
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Hypertension-misattributed kidney disease in African Americans. Kidney Int (2013) 1.23
Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant (2013) 1.21
Host APOL1 genotype is independently associated with proteinuria in HIV infection. Kidney Int (2013) 0.98
Impact of coronary artery calcification on all-cause mortality in individuals with and without hypertension. Atherosclerosis (2012) 0.97
The new era of APOL1-associated glomerulosclerosis. Nephrol Dial Transplant (2012) 0.93